Time
|
Topic
|
7:00 - 9:00 a.m.
|
Breakfast Session 1
"Asia-Pacific Stroke Initiatives“
- The Thailand Experience (N. Poungvarin)
- China and It's Stroke Prevention Plan (Y.N. Huang)
- The Pakistan Campaign Against Stroke (M. Wasay)
- The Philippine Stroke Initiative (J. Cuanang)
|
7:00 - 9:00 a.m
|
Breakfast Session 2
"Recent Progress in Stroke Guidelines“
- Saudi Arabia ( A. Alreshaid)
- China (C. Lu)
- Indonesia (J. Misbach )
- Thailand (S. Ninhinanda)
- Philippines (E. Bitanga)
|
7:00 - 9:00 a.m
|
Breakfast Session 3
"Rehabilitation After Stroke“
- Role of Neuroplasticity in Functional Recovery (M.
Guerrero )
- Role of Occupational therapy in Ischemic Strokes (S.J.
Uy)
- Effectiveness of Botulinum Toxin in Stroke Spasticity (B.
Mancao)
- Stroke Outcomes After Rehabilitation (S.J. Ryu)
|
9:00 - 10:30
a.m.
|
PLENARY SESSION 3
"Updates on Evidence-Based Stroke Therapy"
- Optimal Approach to Thrombolytic Therapy in Acute
Stroke (A. Davalos)
- Choices for Rational Antiplatelet Therapy in Ischemic
Strokes ( W. Eisert )
- Anticoagulation in Cardiac and Non-Cardiac Strokes: New
or Old Agents and What Is Indicated? (N.V. Ramani)
|
10:30- 11:30
A.M.
|
Oral Paper Presentation
|
11:30.-1:00 P.M.
|
LUNCH SYMPOSIUM
"Role of Angiotensin II Receptor Blockade in Stroke
Prevention"
|
1:00-2:30 P.M.
|
PLENARY SESSION 4
"The Spectrum of Vascular Dementia“
- Classifying Vascular Dementia (C. Chen)
- Pathophysiology and Current Treatment (G. Roman)
- The VADAS-COG (S. Marasigan)
|
2:30-2:45 P.M.
|
Coffee/Tea Break
|
2:45 - 4:30 P.M.
|
Scientific Session 4
"Management of Cerebrovascular Atherothrombotic Disease:
Insights in Anti-Platelet Therapy“
- Role of Platelets in Ischemic Stroke (R. Gan)
- . Risk of Atherothrombotic Events in Patients with
Strokes (J. S. Kim)
- Antiplatelet Therapy for Multi-Vascular High Risk
Patients for Stroke Recurrence (B. Chan)
|
4:30-6:00 P.M.
|
PLENARY SESSION 5
"Optimizing Treatment for Intracerebral Hemorrhage“
- Titration of Blood Pressure in ICH (D. Bonovich)
- Innovative Medical Treatments for Brain Hemorrhage
(S. Schwab)
- Minimally Invasive Treatment for ICH (M. Mehndiratta)
- Updates on ICH Trials (S. Davis)
|